AL-001

· Beijing Anlong Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL-001, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD [Phase 1, Phase 2]